Study of Olaparib and Temozolomide in Patients With Recurrent Small Cell Lung Cancer Following Failure of Prior Chemotherapy
- First Posted Date
- 2015-05-18
- Last Posted Date
- 2022-02-07
- Lead Sponsor
- Zofia Piotrowska
- Target Recruit Count
- 66
- Registration Number
- NCT02446704
- Locations
- 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
🇺🇸Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸Dana Farber Cancer Institute, Boston, Massachusetts, United States
© Copyright 2025. All Rights Reserved by MedPath